In November 2011, Tisch MS was approved by the International Cellular Medicine Society (ICMS), an Institutional Review Board (IRB), to begin a phase I safety and tolerability trial of Mesenchymal Stem Cell-Derived Neural Progenitors in 20 selected Multiple Sclerosis patients. The Food and Drug...
Deirdre Dulak (Tisch MS) presented the following article in Journal Club. Article Title : Placebo-Controlled Trial of Oral Laquinimod for Multiple Sclerosis Reference : G. Comi, D. Jeffery, L. Kappos, X. Montalban, A. Boyko, M.A. Rocca, and M. Filippi. (2012) The New England Journal of Medicine...
The Food and Drug Administration (FDA) made an unannounced site visit to Tisch MS during the week of August 27 in connection with the proposed Tisch MS clinical trial of Mesenchymal Stem Cell-Derived Neural Progenitors (MSC-NPs). As noted in this space in August , the FDA had previously initiated...
Daniel Koffler (Tisch MS) presented the following article in Journal Club. Article Title : Decreased Hydrocortisone Sensitivity of T Cell Function in Multiple Sclerosis Associated Major Depression Reference : A. Fischer, C. Otte, T. Krieger, R. Nichols, S. Krüger, K. Ziegler, K. Schulz, C.Heesen,...
Saud Sadiq, MD (Tisch MS, IMSMP) presented the following article in Journal Club. Article Title: Potassium Channel KIR4.1 as an Immune Target in Multiple Sclerosis Reference: R. Srivastava, M. Aslam, S.R. Kalluri, L. Schirmer, D. Buck, B. Tackenberg, V. Rothhammer, A. Chan, R. Gold, A. Berthele, J...
Jerry Lin (Tisch MS) presented the following article in Journal Club. Article Title: Persistence of Epstein-Barr Virus in Self-Reactive Memory B Cells Reference: S.I. Tracy, K. Kakalacheva, J.D. Lünemann, K. Luzuriaga, J. Middeldorp, and D.A. Thorley-Lawsona. (2012) Journal of Virology. 86 (22):...